OA09200A - Vaccines for malaria. - Google Patents
Vaccines for malaria.Info
- Publication number
- OA09200A OA09200A OA59758A OA59758A OA09200A OA 09200 A OA09200 A OA 09200A OA 59758 A OA59758 A OA 59758A OA 59758 A OA59758 A OA 59758A OA 09200 A OA09200 A OA 09200A
- Authority
- OA
- OAPI
- Prior art keywords
- malaria
- vaccines
- Prior art date
Links
- 201000004792 malaria Diseases 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
- C07K14/445—Plasmodium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/036—Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/879—Salmonella
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/104,735 US5112749A (en) | 1987-10-02 | 1987-10-02 | Vaccines for the malaria circumsporozoite protein |
Publications (1)
Publication Number | Publication Date |
---|---|
OA09200A true OA09200A (en) | 1992-06-30 |
Family
ID=22302087
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
OA59758A OA09200A (en) | 1987-10-02 | 1990-03-29 | Vaccines for malaria. |
Country Status (7)
Country | Link |
---|---|
US (1) | US5112749A (xx) |
EP (1) | EP0383833A4 (xx) |
JP (1) | JPH03500246A (xx) |
AU (1) | AU2813589A (xx) |
DK (1) | DK81290A (xx) |
OA (1) | OA09200A (xx) |
WO (1) | WO1989002924A1 (xx) |
Families Citing this family (62)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2004738A1 (en) * | 1988-12-07 | 1990-06-07 | University Of Leicester | Heat-labile toxin b subunit fusion proteins |
SE8904100D0 (sv) * | 1989-12-05 | 1989-12-05 | Astra Ab | New analysis method |
NZ233255A (en) * | 1989-04-11 | 1993-02-25 | Chiron Corp | Plasmodium cs protein analogues lacking one or more of the repeat epitopes, and containing at least one nonrepeat flanking epitope |
FR2645877B1 (fr) * | 1989-04-12 | 1991-07-05 | Pasteur Institut | Molecules comportant au moins une sequence peptidique porteuse d'un, ou plusieurs, epitope caracteristique d'une proteine produite par p. falciparum au niveau du stade sporozoite et dans les hepatocytes |
EP0418626B1 (en) * | 1989-09-08 | 1993-12-29 | Takeda Chemical Industries, Ltd. | Fused proteins and production thereof |
US5260198A (en) * | 1990-03-31 | 1993-11-09 | Mitsui Toatsu Chemicals, Inc. | Cloned tyrosine phenol-lyase gene, recombinant plasmid containing the same and escherichia coli transformed with the same |
US5241053A (en) * | 1990-09-05 | 1993-08-31 | Takeda Chemical Industries, Ltd. | Fused proteins comprising glycoprotein gD of HSV-1 and LTB |
TW201794B (xx) * | 1991-05-03 | 1993-03-11 | American Cyanamid Co | |
US6169171B1 (en) * | 1992-02-27 | 2001-01-02 | Smithkline Beecham Biologicals (S.A.) | Hybrid protein between CS from plasmodium and HBSAG |
US5928902A (en) * | 1992-02-27 | 1999-07-27 | Smithkline Beecham Biologicals (S.A.) | Hybrid protein between CS from plasmodium and HBsAg |
FR2697022B1 (fr) * | 1992-10-19 | 1994-12-16 | Pasteur Institut | Antigènes de Plasmodium falciparum capables d'induire des anticorps protecteurs à large spectre - Application à la vaccination. |
ATE359370T1 (de) * | 1993-02-22 | 2007-05-15 | Gen Hospital Corp | Heterologe antigene in stämmen zur impfung mit lebendzellen |
WO1994024291A2 (en) * | 1993-04-15 | 1994-10-27 | Washington University | Compositions of antigen containing recombinant salmonella, their use in anti-malarial vaccines and method for their preparation |
US5821074A (en) * | 1993-12-21 | 1998-10-13 | Abbott Laboratories | Method and compositions for enhancing aminolevulinic acid dehydratase assay |
US5565327A (en) * | 1994-03-25 | 1996-10-15 | Duke University | Methods of diagnosing parasitic infections and of testing drug susceptibility of parasites |
US7223739B1 (en) * | 1995-06-07 | 2007-05-29 | Powderject Vaccines, Inc. | Adjuvanted genetic vaccines |
US7045336B1 (en) * | 1995-09-06 | 2006-05-16 | The United States Of America As Represented By The Secretary Of The Army | Bacterial delivery system |
US6036953A (en) * | 1996-11-29 | 2000-03-14 | The General Hospital Corporation | Heterologous antigens in live cell V. cholerae strains |
US7189402B1 (en) * | 1998-02-06 | 2007-03-13 | Research Development Foundation | Live vaccine for human immunodeficiency virus |
CN100352930C (zh) | 1998-02-27 | 2007-12-05 | 宾夕法尼亚州立大学托管会 | 疫苗、免疫治疗剂及其应用方法 |
BR0008645A (pt) * | 1999-03-03 | 2002-01-22 | Univ Pennsylvania | Métodos de induzir uma resposta imunológica contra um imunógeno em um indivìduo, de reduzir rejeição de células, tecido ou órgão doadores nã0-assemelhados em um indivìduo e uma resposta imunológica dominante em um indivìduo e de expandir uma subpopulação de células t associadas com uma resposta imunológica especìfica, plasmìdeo, e, composição |
CN1196495C (zh) | 1999-04-30 | 2005-04-13 | 宾夕法尼亚大学理事会 | 突变的人cd80及其制备和应用组合物和方法 |
CA2415187C (en) * | 2000-07-14 | 2013-06-18 | David B. Weiner | Dna vaccines encoding hiv accessory proteins |
US6733994B2 (en) | 2000-10-04 | 2004-05-11 | The Trustees Of The University Of Pennsylvania | Highly expressible genes |
ATE488600T1 (de) * | 2002-12-23 | 2010-12-15 | Bristol Myers Squibb Co | Produktqualitätsverbesserung in säugerzellkulturverfahrenzur proteinproduktion |
NZ570709A (en) | 2003-06-13 | 2010-04-30 | Univ Pennsylvania | Nucleic acid sequences encoding and compositions comprising IgE signal peptide and/or IL-15 and methods for using the same |
WO2004112706A2 (en) | 2003-06-13 | 2004-12-29 | The Trustees Of The University Of Pennsylvania | Vaccines, immunotherapeutics and methods for using the same |
US20080274140A1 (en) * | 2004-11-19 | 2008-11-06 | David B Weiner | Vaccines and Methods for Using the Same |
JP5346588B2 (ja) | 2006-01-13 | 2013-11-20 | ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア | コドン最適化したil−15を用いるワクチンおよび免疫治療とその使用方法 |
EP1981905B1 (en) | 2006-01-16 | 2016-08-31 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | Chlamydia vaccine |
CN105132439A (zh) | 2006-07-28 | 2015-12-09 | 宾夕法尼亚大学托管会 | 改进的疫苗及其使用方法 |
WO2009124312A2 (en) * | 2008-04-04 | 2009-10-08 | The Trustees Of The University Of Pennsylvania | Consensus sequences of chikungunya viral proteins, nucleic acid molecules encoding the same, and compositions and methods for using the same |
WO2009124309A2 (en) * | 2008-04-04 | 2009-10-08 | The Trustees Of The University Of Pennsylvania | Vaccines and immunotherapeutics using il-28 and compositions and methods of using the same |
JP4797050B2 (ja) * | 2008-09-09 | 2011-10-19 | 前田製品販売株式会社 | 高さ調整機構付コンクリート製品 |
JP5753090B2 (ja) | 2008-10-29 | 2015-07-22 | ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア | 改良型hcvワクチンおよびその使用方法 |
US8921536B2 (en) | 2008-10-29 | 2014-12-30 | The Trustees Of The University Of Pennsylvania | HCV vaccines and methods for using the same |
US9050287B2 (en) | 2009-01-23 | 2015-06-09 | The Trustees Of The University Of Pennsylvania | Vaccines for human papilloma virus and methods for using the same |
CA2653478A1 (en) * | 2009-01-23 | 2010-07-23 | Gregg Martin | Automated wash system for industrial vehicles |
EP2818175B1 (en) | 2009-05-05 | 2018-11-21 | Cadila Healthcare Limited | Combined measles-malaria vaccine |
KR20120093163A (ko) | 2009-09-14 | 2012-08-22 | 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 | Il-15 수용체 알파 및/또는 이를 인코딩하는 핵산 분자를 포함하는 백신 및 면역 치료제, 및 이를 이용하는 방법 |
EP2498814B1 (en) | 2009-11-02 | 2015-09-09 | The Trustees of the University of Pennsylvania | Foot and mouth disease virus (fmdv) consensus proteins, coding sequences therefor and vaccines made therefrom |
US8298820B2 (en) | 2010-01-26 | 2012-10-30 | The Trustees Of The University Of Pennsylvania | Influenza nucleic acid molecules and vaccines made therefrom |
AU2011213559B2 (en) | 2010-02-08 | 2015-05-07 | The Trustees Of The University Of Pennsylvania | Nucleic acid molecules encoding RANTES, and compositions comprising and methods of using the same |
EP3536703B1 (en) | 2010-11-12 | 2021-05-26 | The Trustees of the University of Pennsylvania | Consensus prostate antigens, nucleic acid molecules encoding the same and uses thereof |
US9243041B2 (en) | 2011-01-31 | 2016-01-26 | The Trustees Of The University Of Pennsylvania | Nucleic acid molecules encoding novel herpes antigens, vaccine comprising the same, and methods of use thereof |
CA2827080C (en) | 2011-02-11 | 2022-09-20 | The Trustees Of The University Of Pennsylvania | Nucleic acid molecule encoding hepatitis b virus core protein and vaccine comprising the same |
US9238679B2 (en) | 2011-02-11 | 2016-01-19 | The Trustees Of The University Of Pennslyvania | Nucleic acid molecule encoding hepatitis B virus core protein and surface antigen protein and vaccine comprising the same |
ES2873233T3 (es) | 2011-06-24 | 2021-11-03 | Realco | Kit y procedimiento de detección de biopelículas |
AU2012321315B2 (en) | 2011-07-11 | 2016-04-14 | Inovio Pharmaceuticals, Inc | Cross-protective arenavirus vaccines and their method of use |
EP3443982A1 (en) | 2011-10-12 | 2019-02-20 | The Trustees of the University of Pennsylvania | Vaccines for human papilloma virus and methods for using the same |
KR101913674B1 (ko) | 2011-10-24 | 2018-10-31 | 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 | 개선된 hcv 백신 및 이것을 사용하는 방법 |
KR20140116095A (ko) | 2011-12-12 | 2014-10-01 | 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 | Mrsa pbp2a 및 이의 단편들을 포함하는 단백질, 이를 인코딩한 핵산, 및 mrsa 감염을 예방 및 치료하기 위한 조성물 및 그의 용도 |
BR112014014078A2 (pt) | 2011-12-12 | 2018-10-09 | The Trustees Of The University Of Pennsylvania | composições compreendendo constructos genéticos il-12 aperfeiçoados e vacinas, imunoterapêuticos e métodos de uso dos mesmos |
AU2013245950B2 (en) | 2012-04-10 | 2016-04-21 | The Trustees Of The University Of Pennsylvania | Human respiratory syncytial virus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same |
ES2686325T3 (es) * | 2012-12-07 | 2018-10-17 | Lohmann Animal Health Gmbh | Preparación de vacunas vivas |
CN105307678A (zh) | 2013-03-12 | 2016-02-03 | 宾夕法尼亚大学理事会 | 用于人乳头状瘤病毒的改进疫苗及其使用方法 |
US11419925B2 (en) | 2013-03-15 | 2022-08-23 | The Trustees Of The University Of Pennsylvania | Cancer vaccines and methods of treatment using the same |
CN114045295A (zh) | 2013-03-15 | 2022-02-15 | 宾夕法尼亚大学理事会 | 口蹄疫病毒(fmdv)共有蛋白、其编码序列以及由其制造的疫苗 |
RU2751252C1 (ru) | 2017-12-13 | 2021-07-12 | Иновио Фармасьютикалз, Инк. | Мезотелин-нацеленные вакцины от рака и их применение |
KR20230116954A (ko) | 2017-12-13 | 2023-08-04 | 이노비오 파마수티컬즈, 인크. | Muc16을 표적화하는 암 백신 및 이의 용도 |
MX2020006216A (es) | 2017-12-13 | 2020-08-31 | Inovio Pharmaceuticals Inc | Vacunas contra el cancer dirigidas a prame y sus usos. |
CN112457411B (zh) * | 2020-11-25 | 2022-11-01 | 中国药科大学 | 一种幽门螺杆菌多表位串联融合蛋白lhuc及其制备方法和应用 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6114889A (ja) * | 1984-06-29 | 1986-01-23 | フアナツク株式会社 | 内圧防爆構造の電動式産業用ロボツト |
US4735801A (en) * | 1982-09-07 | 1988-04-05 | Board Of Trustees Of Leland Stanford Jr. University | Novel non-reverting salmonella live vaccines |
US4550081A (en) * | 1980-05-19 | 1985-10-29 | The Board Of Trustees Of The Leland Stanford Jr. University | Non-reverting salmonella |
US4837151A (en) * | 1980-05-19 | 1989-06-06 | The Board Of Trustees Of The Leland Stanford Junior University, Stanford University | Live vaccines comprising two mutations and foreign antigen |
US4761372A (en) * | 1981-01-12 | 1988-08-02 | New York University | Mutant enterotoxin of E. coli |
US4411888A (en) * | 1981-06-22 | 1983-10-25 | The University Of Rochester | Composition of a novel immunogen for protection against diarrheal disease caused by enterotoxigenic Escherichia coli |
US4632830A (en) * | 1981-07-31 | 1986-12-30 | The United States Of America As Represented By The Secretary Of The Army | Oral vaccine for immunization against enteric disease |
US4758655A (en) * | 1983-01-03 | 1988-07-19 | Scripps Clinic And Research Foundation | Synthetic polypeptide corresponding to a portion of the heat-labile enterotoxin of escherichia coli, compositions and methods of therewith |
GB8314645D0 (en) * | 1983-05-26 | 1983-06-29 | Wellcome Found | Bivalent vaccines |
IL69558A (en) * | 1983-08-23 | 1988-06-30 | Yeda Res & Dev | Synthetic cholera vaccine |
US4808700A (en) * | 1984-07-09 | 1989-02-28 | Praxis Biologics, Inc. | Immunogenic conjugates of non-toxic E. coli LT-B enterotoxin subunit and capsular polymers |
IL78775A (en) * | 1985-05-15 | 1992-06-21 | Biotech Australia Pty Ltd | Oral vaccines |
CA1331355C (en) * | 1986-04-21 | 1994-08-09 | Bioenterprises Pty. Ltd | Immunopotentation |
EP0249449A1 (en) * | 1986-06-11 | 1987-12-16 | Enterovax Research Pty. Ltd. | Bacterial strain for live vaccines |
JPH0284172A (ja) * | 1988-07-21 | 1990-03-26 | Smithkline Beckman Corp | 異種遺伝子の発現能を有し、組換え型ワクチンとして有用なサルモネラ形質転換体 |
-
1987
- 1987-10-02 US US07/104,735 patent/US5112749A/en not_active Expired - Fee Related
-
1988
- 1988-09-30 JP JP1500257A patent/JPH03500246A/ja active Pending
- 1988-09-30 WO PCT/US1988/003376 patent/WO1989002924A1/en not_active Application Discontinuation
- 1988-09-30 AU AU28135/89A patent/AU2813589A/en active Granted
- 1988-09-30 EP EP19890900389 patent/EP0383833A4/en not_active Ceased
-
1990
- 1990-03-29 OA OA59758A patent/OA09200A/xx unknown
- 1990-03-30 DK DK081290A patent/DK81290A/da not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
DK81290A (da) | 1990-05-14 |
DK81290D0 (da) | 1990-03-30 |
AU2813589A (en) | 1989-04-18 |
US5112749A (en) | 1992-05-12 |
EP0383833A1 (en) | 1990-08-29 |
WO1989002924A1 (en) | 1989-04-06 |
EP0383833A4 (en) | 1990-11-07 |
JPH03500246A (ja) | 1991-01-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
OA09200A (en) | Vaccines for malaria. | |
DE3863660D1 (en) | Aminomethylheterocyclen. | |
DE3864664D1 (en) | Koerperstativ. | |
DE3854331D1 (en) | Eisnachweisschaltung. | |
DE3765420D1 (en) | Huelsengummifeder. | |
DE3852484D1 (en) | Ionomerzubereitung. | |
DE3862796D1 (en) | Emp - generator. | |
DE3860893D1 (en) | Waescheweichmacherzusammensetzung. | |
ZA88149B (en) | Anti-reproductive vaccines | |
DE3861059D1 (en) | Antihypercholesterin-beta-lactone. | |
DE3866184D1 (en) | Buten-1-copolymer. | |
DE3769639D1 (en) | Tuerschliesser. | |
DE3852648D1 (en) | Hypersystolischer reed-solomon-encoder. | |
OA08200A (en) | Vaccine. | |
OA08199A (en) | Vaccine. | |
DE3850382D1 (en) | Polyester-film. | |
DE3860833D1 (en) | Breitstreckwalze. | |
ZA909838B (en) | Malaria vaccine | |
DE3863381D1 (en) | Azoreaktivfarbstoffe. | |
EP0266401A4 (en) | VACCINE. | |
DE3853279D1 (en) | Laryngoskop. | |
DE3860037D1 (en) | Plungerpumpe. | |
GB8704647D0 (en) | Vaccine | |
DE3862634D1 (en) | Buerstenherstellungsmaschine. | |
DE3862792D1 (en) | Tuerschliesser. |